Holen Sie sich die Stockscreener-App
24.30
1.46%
-0.36
Handel nachbörslich:
24.34
0.04
+0.16%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Pfizer Receives Early Termination of FTC Review for Metsera Acquisition - geneonline.com
Pfizer Q3 Revenue Falls 7% To US$16.7 Billion - BusinessToday Malaysia
Defining The 'Superior' Bid In Pfizer-Novo Legal Battle - Law360
Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera - Denver Gazette
Pfizer’s Earnings Call: Strategic Gains Amid Challenges - TipRanks
Pfizer (NYSE:PFE) Trading Down 1.4%Time to Sell? - MarketBeat
PFIZER INC : JP Morgan is Neutral - MarketScreener
Metsera in the middle of Novo, Pfizer bidding war - BioWorld MedTech
Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup MetseraWSJ - The Wall Street Journal
Pfizer and Novo fatten their bids for weight-loss drugmaker Metsera - Axios
Pfizer Weight-Loss $9B Suit: Delaware Court Holds Off Amid High-Stakes Fight Over Metsera - USA Herald
Pfizer ‘Unwavering’ In Pursuit Of Metsera - Citeline News & Insights
Pfizer Earnings: In-Line Quarter Despite Covid Product Weakness as Metsera Drama Intensifies - Morningstar
Pfizer Inc (PFE) Q3 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... By GuruFocus - Investing.com Canada
Pfizer Inc (PFE) Q3 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... - Yahoo Finance
Weight-loss wars: $10bn hostile battle pits Pfizer against Novo Nordisk - Financial Times
Novo Nordisk Boosts Metsera Bid To $10B After Pfizer Suit - Law360
Pfizer Can't Freeze $9B Weight-Loss Drug Fight For Now - Law360
How Pfizer's (PFE) Metsera Legal Fight and Q3 Dip Could Reshape Its Innovation Strategy - Yahoo Finance
Novo, Pfizer Are Battling To Buy The Future Of Weight-Loss — But Viking Already Owns It - Benzinga
Traders Purchase Large Volume of Pfizer Call Options (NYSE:PFE) - MarketBeat
Pfizer, Novo Nordisk Intensify Fight For Metsera As Buyout Offers Continue To Climb - Benzinga
Novo Nordisk ups Metsera offer to $10B, outbidding Pfizer - The Business Journals
Pfizer Is Losing Its Fight With Novo Nordisk to Get Back in the Obesity-drug Game - 富途牛牛
Pfizer Narrows Its Outlook And Keeps The Optimism Flowing - Finimize
Novo Nordisk Outbids Pfizer In $10 Billion Metsera Takeover Battle - Finimize
Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera - Barron's
Novo, Pfizer Boost Metsera Bids in Obesity Startup Battle - MarketScreener
Pfizer Q3 Revenue Trends Are Uneven, Cost Cuts Drive EarningsPfizer (NYSE:PFE) - Benzinga
Pfizer Profit Falls Amid Lower Covid-19 Drug Demand - The Wall Street Journal
Pfizer Stock Falls on Third-Quarter Earnings. What Covid-19 Has to Do With It. - Barron's
Pfizer, Novo Boost Bids for Obesity Drugmaker Metsera in Takeover Saga - Bloomberg
Pfizer Q3 2025 slides: EPS beats expectations as company raises guidance - Investing.com
Novo Nordisk tops Pfizer in bidding war for obesity startup Metsera - Proactive financial news
Metsera’s Shares Spike Amid Acquisition Proposals from Novo Nordisk and Pfizer - StocksToTrade
Pfizer (PFE) Q3 2025 Earnings Call Transcript - The Globe and Mail
Transcript : Pfizer Inc., Q3 2025 Earnings Call, Nov 04, 2025 - MarketScreener
Delaware court won't rule on Pfizer/Novo battle for Metsera today - Seeking Alpha
Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo - Reuters
Metsera again chooses Novo as bidding war with Pfizer intensifies - BioPharma Dive
Pfizer : Quarterly Corporate PerformanceThird Quarter 2025 Prepared Remarks - MarketScreener
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up - Yahoo Finance
Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer - Houston Chronicle
Pfizer reports strong Q3 earnings, raises full-year profit guidance - Proactive financial news
Pfizer Q3 Earnings Beat Estimates, Sales Decline as COVID Demand Cools - TradingView
Pfizer’s Q3 Earnings Beat on Top and Bottom Lines - AOL.com
Pfizer Inc. Reaffirms Earnings Guidance for the Full Year of 2025 - MarketScreener
Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup - The Wall Street Journal
Pfizer & Novo boost Metsera bids, Hertz stock skyrockets - Yahoo Finance
Novo Nordisk Hikes Metsera Bid to up to $10B in Competition With Rival Pfizer - U.S. News & World Report
Global markets live: Tesla, Amazon, Palantir, Pfizer, Merck… - MarketScreener
Pfizer Inc. 2025 Q3ResultsEarnings Call Presentation (NYSE:PFE) 2025-11-04 - Seeking Alpha
Pfizer says drug pricing agreement with US government has no impact on 2025 guidance - MarketScreener
Pfizer’s revenue falls as COVID sales and vaccine recommendations continue to fade - MSN
Here's What Key Metrics Tell Us About Pfizer (PFE) Q3 Earnings - Yahoo! Finance Singapore
Pfizer Boosts Profit View While Chasing Obesity Startup Metsera - Bloomberg
Dow Dips Over 400 Points; Pfizer Earnings Top Estimates - Benzinga
Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows - Yahoo Finance
0.78%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):